From Concept to Medicine - A Comprehensive Drug Development Journey

Join us for a fascinating exploration of one of humanity's oldest and most influential medicines - aspirin. In this inaugural episode, we dive deep into the remarkable journey of acetylsalicylic acid, from its ancient origins in willow bark to its modern-day applications. Our expert guests will guide us through the pivotal moments in aspirin's history, including its groundbreaking synthesis at Bay...

This episode offers listeners a chance to become more knowledgeable on how they can audit preparedness, by using internal audits. We will discuss corrective action processes and share strategies for ensuring ongoing quality improvement. Our goal is to help empower these organization with information on how to maintain compliance and risk management. The ultimate intention is to show how this can e...

This episode serves as a refreshing dive into the key aspects of documentation in clinical trials, making it much more than a dry overview. We'll journey through aspects of informed consent procedures, adverse event reporting, and the very best record-keeping practices. Ultimately, the intention of this exploration is to provide reliable guidance on how to maintain accurate audit trails. By the en...

In this episode, we revisit the critical operational components that make up clinical research. This discussion will offer effective methods for monitoring the study process and the key quality assurance procedures that are necessary to support compliance. We have prepared some practical advice that will give insight into optimizing your processes and will include how to successfully manage risk a...

his episode recaps the essential principles of current Good Clinical Practice (cGCP) and provides a comprehensive overview of the regulatory framework governing clinical trials. We emphasize the key ethical, legal, and operational standards that underpin this framework. A core focus is on how these concepts work to protect participants involved in research and simultaneously ensure the delivery of...

This episode explores the fundamental principles of data integrity and its importance in ensuring trial trustworthiness. It delves into the critical role of informed consent, which is the ethics and heart of clinical research, emphasizing the need for willingly and knowingly involved people in these trials. Finally, it explores the best practices in recordkeeping for clinical trials. Finally, the...

This episode explores the critical processes of risk management and quality assurance within the clinical research environment. It will focus on GMPs, premises, processes, products, and procedures, and how they impact quality. Beyond that, the episode discusses the physical space of equipment and how that impacts the final product. The episode details effective strategies for monitoring compliance...

This episode explores the fundamental components of clinical trial protocols, the roles assumed by investigators in these trials, and the essential nature of thorough documentation. It will focus on the importance of having well-defined objectives and how researchers need to be on the same page about how to collect data and how to analyze it. From there, the need for safety monitoring and appropri...

This episode traces the progression of cGCP standards, commencing from the foundational ethical principles of early clinical research through to the contemporary regulatory landscape. Key milestones are examined, accompanied by landmark cases and regulatory transitions that have significantly shaped current practices in the field. Understanding how these elements came to be what they are today wil...

This episode defines current Good Clinical Practices (cGCPs) and explores their pivotal role in safeguarding trial participants and ensuring the integrity of data. It delves into the ethical considerations inherent in clinical research, emphasizing the significance of informed consent as a cornerstone of ethical practice. The discussion also highlights the critical importance of meticulous protoco...

Details and explains the enforcement mechanisms that regulatory agencies employ to make sure cGCP compliance. Also explained is the role that audit procedures, risk-based inspections, and corrective actions have. This includes the ways that all of the previous measures drive continuous improvement and to safe guard participant safety in clinical research. Discussions on good documentation practice...

This is a dive into ICH guidelines, specifically E6(R2), which is a corner stone of current Good Clinical Practices, that shapes cGCP worldwide. We discuss the reasoning behind harmonization efforts and the way these standards are influencing national regulations. This also discusses that ICH Guidelines, particularly the E6 R2 guideline, is about ensuring that clinical trials are conducted ethical...

Explore the European Medicines Agency (EMA) and the ways this group works with international bodies to regulate clinical trials. This podcast episode discusses the ICH harmonization, and how this integrates with global standards, while taking into account the regional differences. Explore ICH's E6R3 draft guideline and ICH's Q series which provides guidance on how to achieve consistent quality in...

This episode dives into the complex world of U.S. regulations for clinical trials. Examine the detailed provisions within U.S. regulations for clinical trials as we explain how FDA guidance documents, relevant sections of 21 CFR, and associated Q&A documents shape current clinical practices. We will also break down enforcement strategies, such as inspection protocols, providing practical examp...

Delve into the expansive regulatory framework that governs clinical trials. Discover the critical roles played by key agencies such as the FDA, EMA, and WHO, and understand how ICH guidelines, like ICH E6(R2), fit into the overall picture. We'll also explore the history and evolution of these regulations, tracing their origins and how they've adapted over time. This episode will highlight the inte...

This episode recaps the entire series, summarizing key lessons and insights while looking forward to ongoing innovation. Final reflections by Host and SME, celebrating the learning journey and setting visions for the future are shared. Analysis of the major moments and topics of the year are featured, bringing the season full circle. The discussion highlights pre-clinical testing, the ADME, and GL...

This episode discusses strategic risk management and flexible design to prepare for future uncertainties in drug development. Dialogue on contingency planning, scenario analysis, and adaptive strategies with real-world examples is presented. Analysis is focused on building adaptability into the process and thinking ahead. Various techniques for managing strategic risk, including contingency planni...

This episode looks ahead at emerging manufacturing innovations—such as modular and continuous systems—that promise efficiency gains. Conversation on technology trends, projected industry impacts, and documented case studies are analyzed. Discussion around the traditional methods are compared to these new technologies, such as 3-D printing and modular systems. The various processes and technologies...

This episode analyzed how anticipated policy changes and regulatory reforms may impact the drug development landscape. Discussion on current debates, potential shifts, and strategic responses backed by recent examples were presented. Discussions on current policy standards are included and discussions about proposed regulatory shifts are also provided. Among the areas covered are dietary supplemen...

This episode explores novel clinical trial designs (basket, umbrella trials) aimed at increasing efficiency and patient benefit. Dialogue on design principles, adaptive features, and case studies from current literature are provided. Discussions around adaptive designs and the benefits as they relate to the future of drug development are analyzed. The efficiency gains of umbrella trials as compare...

This episode discusses the challenge of balancing rapid innovation with rigorous safety standards in modern drug development. Conversation on risk management, ethical considerations, and regulatory requirements are presented with detailed examples. Discussions start with how a drug process happens and why pre-clinical phases of research exist. The importance of the FDA and ICH guidelines is highli...

This episode explored models of global collaboration and open innovation that are transforming drug development worldwide. Dialogue on partnerships, data sharing, and collaborative research with real-world case references is provided. Discussions on global collaboration and why it is a growing necessity are included. There are also many OPR&D examples to show the many forms of collaboration. S...

This episode dives deep into how Al continues to influence every stage of drug research, from discovery to clinical trials. Discussion on new algorithms, data integration, and future potentials are backed by literature examples. The conversation includes what drives the need for Al, such as cost or speed, and the safety surrounding the use of Al. The integration of Al into many areas of drug devel...

This episode discusses the move toward sustainable practices and green chemistry in drug development and manufacturing. Dialogue on environmental initiatives, innovative chemistry approaches, and documented case studies is provided. There is much discussion on pollution, waste, resource depletion, and economics. The episode also explores the 12 core principles and some of the most important, inclu...

This episode examined the role of big data and digital health records in shaping future drug development decisions. A conversation on data analytics, privacy concerns, and clinical applications with detailed real-world insights is offered. There's talk about how Al and machine learning tools can find patterns and connections within the massive amounts of data. The conversation covers not only targ...